Cyclerion Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CYCN, updated each market day.
CYCN AI Sentiment
AI sees no strong directional signal for Cyclerion Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Cyclerion Therapeutics, Inc. Common Stock
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Sector
Exchange
Market Cap
$12,774,426
Cap Tier
Employees
1
Headquarters
CAMBRIDGE, MA
Listed Since
March 18, 2019
Website
CYCN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CYCN Volatility
Cyclerion Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
